JP2014167010A5 - - Google Patents

Download PDF

Info

Publication number
JP2014167010A5
JP2014167010A5 JP2014090998A JP2014090998A JP2014167010A5 JP 2014167010 A5 JP2014167010 A5 JP 2014167010A5 JP 2014090998 A JP2014090998 A JP 2014090998A JP 2014090998 A JP2014090998 A JP 2014090998A JP 2014167010 A5 JP2014167010 A5 JP 2014167010A5
Authority
JP
Japan
Prior art keywords
use according
dermatophyte
infection
trichophyton
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014090998A
Other languages
English (en)
Other versions
JP6199797B2 (ja
JP2014167010A (ja
Filing date
Publication date
Priority claimed from GBGB0526120.1A external-priority patent/GB0526120D0/en
Application filed filed Critical
Publication of JP2014167010A publication Critical patent/JP2014167010A/ja
Publication of JP2014167010A5 publication Critical patent/JP2014167010A5/ja
Application granted granted Critical
Publication of JP6199797B2 publication Critical patent/JP6199797B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (11)

  1. Xはアルギニンであり、nは5から15である、
    式I:
    (X)n (I)
    で表されるアミノ酸配列を含み、該アミノ酸配列の0又は1つが置換されている、環状ペプチドの、真菌感染の治療のための医薬の製造における使用。
  2. 真菌感染が皮膚糸状菌感染である請求項1に記載の使用。
  3. 前記ペプチドが5から13のアミノ酸を含む請求項1に記載の使用。
  4. 前記ペプチドがR−R−R−R−R−R−Rである請求項1に記載の使用。
  5. 皮膚糸状菌感染が白癬感染である請求項2に記載の使用。
  6. 皮膚糸状菌感染が、Trichophyton, Epidermophyton又はMicrosporum属の皮膚糸状菌によって引き起こされる請求項2に記載の使用。
  7. 皮膚糸状菌が、Trichophyton spp.である請求項6に記載の使用。
  8. 皮膚糸状菌が、Trichophyton interdigitaleである請求項7に記載の使用。
  9. 皮膚糸状菌が、Trichophyton rubrumである請求項7に記載の使用。
  10. 真菌感染が、爪甲真菌症である請求項1に記載の使用。
  11. Xはアルギニンであり、nは5から15である、
    式I:
    (X)n (I)
    で表されるアミノ酸配列を含み、該アミノ酸配列の0又は1つが置換されている、環状ペプチドの製薬上の有効量と、製薬上許容されうるキャリアー、賦形剤又は希釈剤とを含有する薬剤組成物。
JP2014090998A 2005-12-22 2014-04-25 環状抗微生物ペプチド Active JP6199797B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0526120.1 2005-12-22
GBGB0526120.1A GB0526120D0 (en) 2005-12-22 2005-12-22 Therapeutic peptides
US77650506P 2006-02-24 2006-02-24
US60/776,505 2006-02-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008546630A Division JP5559477B2 (ja) 2005-12-22 2006-12-21 環状抗微生物ペプチド

Publications (3)

Publication Number Publication Date
JP2014167010A JP2014167010A (ja) 2014-09-11
JP2014167010A5 true JP2014167010A5 (ja) 2014-12-18
JP6199797B2 JP6199797B2 (ja) 2017-09-20

Family

ID=37836928

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008546630A Active JP5559477B2 (ja) 2005-12-22 2006-12-21 環状抗微生物ペプチド
JP2012252220A Expired - Fee Related JP6050096B2 (ja) 2005-12-22 2012-11-16 環状抗微生物ペプチド
JP2014090998A Active JP6199797B2 (ja) 2005-12-22 2014-04-25 環状抗微生物ペプチド

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008546630A Active JP5559477B2 (ja) 2005-12-22 2006-12-21 環状抗微生物ペプチド
JP2012252220A Expired - Fee Related JP6050096B2 (ja) 2005-12-22 2012-11-16 環状抗微生物ペプチド

Country Status (15)

Country Link
US (2) US8324154B2 (ja)
EP (4) EP2348039A3 (ja)
JP (3) JP5559477B2 (ja)
KR (1) KR101413746B1 (ja)
AU (1) AU2006327973B2 (ja)
CA (1) CA2655448C (ja)
CY (1) CY1113770T1 (ja)
HK (1) HK1121462A1 (ja)
IL (2) IL192373A (ja)
MX (1) MX2008008291A (ja)
NO (1) NO346186B1 (ja)
PL (1) PL1976863T3 (ja)
RU (1) RU2463308C2 (ja)
WO (1) WO2007072037A1 (ja)
ZA (1) ZA200806329B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2655448C (en) * 2005-12-22 2016-09-06 Novabiotics Limited Cyclic antimicrobial peptides
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
WO2010080836A2 (en) 2009-01-06 2010-07-15 C3 Jian, Inc. Antibacterial and antifungal peptides
WO2012135846A1 (en) * 2011-04-01 2012-10-04 Northeastern University Methods of eradicating bacterial cell populations
EP2794645A1 (en) * 2011-12-21 2014-10-29 Regents of the University of Minnesota Cationic peptides and use of such peptides for inhibiting exotoxin production
KR101502797B1 (ko) * 2012-08-22 2015-03-17 연세대학교 산학협력단 신규한 양친매성 고리형 펩티드, 이의 제조방법 및 이를 포함하는 안정한 자기조립 나노전달체
US9082888B2 (en) 2012-10-17 2015-07-14 New York University Inverted orthogonal spin transfer layer stack
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
ES2739613T3 (es) 2014-05-21 2020-02-03 Entrada Therapeutics Inc Péptidos que penetran en las células y sus métodos de preparación y su uso
US10456443B2 (en) 2014-08-27 2019-10-29 Ohio State Innovation Foundation Peptidyl calcineurin inhibitors
US10017542B2 (en) * 2015-03-23 2018-07-10 Riptide Bioscience, Inc. Antimicrobial peptides and methods of use thereof
KR101692992B1 (ko) 2015-05-20 2017-01-17 연세대학교 산학협력단 고리형 펩타이드의 사전 활성화 합성방법 및 이에 따라 합성된 고리형 펩타이드
WO2019148194A2 (en) 2018-01-29 2019-08-01 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-nfat interaction
EP3755351A4 (en) 2018-02-22 2021-11-24 Entrada Therapeutics, Inc. COMPOSITIONS AND TREATMENT METHODS FOR MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY
EP3790890A4 (en) 2018-05-09 2022-03-02 Ohio State Innovation Foundation CYCLIC PEPTIDES OF CELL PENETRATION WITH ONE OR MORE HYDROPHOBIC RESIDUES
GB202010268D0 (en) * 2020-07-03 2020-08-19 Novabiotics Ltd Nail formulations and treatment regimes
CN115716865B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-苏-酪-缬-亮肽及制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051842A (en) 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de) 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
CA2145093C (en) 1992-09-25 2007-04-10 Lawrence Leroy Kunz Therapeutic inhibitor of vascular smooth muscle cells
CA2227292A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
DE19534177A1 (de) * 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity
US6096707A (en) * 1997-07-11 2000-08-01 Biotie Therapies Ltd. Integrin binding peptide and use thereof
US6951652B2 (en) * 1998-07-29 2005-10-04 Biosynth S.R.L. Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
WO2002090503A2 (en) * 2001-05-04 2002-11-14 The Scripps Research Institute Anti-microbial peptides and compositions
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
AU2003228896A1 (en) * 2002-05-06 2003-11-17 The Scripps Research Institute Anti-microbial peptides and compositions
AU2003297657A1 (en) * 2002-11-29 2004-06-23 Adaptive Therapeutics, Inc. Antifungal therapeutic agents
US6783677B1 (en) * 2003-02-06 2004-08-31 Mayyar Systems, Inc. Anaerobic film biogas digester system
US7671011B2 (en) * 2003-06-19 2010-03-02 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
ATE479704T1 (de) * 2004-08-18 2010-09-15 Novabiotics Ltd Antimikrobielle peptide mit einem arginin- und /oder lysin-haltigen motiv
CA2655448C (en) * 2005-12-22 2016-09-06 Novabiotics Limited Cyclic antimicrobial peptides

Similar Documents

Publication Publication Date Title
JP2014167010A5 (ja)
JP2014515013A5 (ja)
PH12020551089A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
JP2013032389A5 (ja)
JP2017537066A5 (ja)
WO2013123215A3 (en) Antiviral drugs for treatment of arenavirus infection
PH12018500904A1 (en) Peptide macrocycles against acinetobacter baumannii
EA201891103A1 (ru) Композиции для лечения спинальной мышечной атрофии
JP2013518107A5 (ja)
NZ748966A (en) Functionalized benzamide derivatives as antiviral agents against hbv infection
JP2012136541A5 (ja)
BR112015021027A2 (pt) compostos terapêuticos
JP2019516735A5 (ja)
JP2014051497A5 (ja)
NZ732391A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
EA026667B9 (ru) Фармацевтическая композиция для лечения вируса гепатита с
JP2013520405A5 (ja)
JP2013509429A5 (ja)
EA032938B1 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
JP2015516419A5 (ja)
AR085856A1 (es) Formas cristalinas del acido (2s)-2-ter-butoxi-2-(4-(2,3-dihidropirano[4,3,2-de]quinolin-7-il)-2-metilquinolin-3-il)acetico
JP2017518982A5 (ja)
JP2017515840A5 (ja)
JP2016532632A5 (ja)
RU2016112257A (ru) Композиция для лечения гипертензии и/или фиброза